[Heavy] Abbott officially canceled the transaction to acquire US Airil

In February 2016, Abbott’s announcement of a $5.8 billion acquisition of US Airil sparked heated discussions in the industry. However, the two companies continued to fluctuate. First, Abbott acquired St. Jude for $25 billion in April, and then continued to have Abbott and A. Unpleasant news came out, and a series of rumors of cooperation problems. Various conjectures were settled this week. On Wednesday (December 7th), Abbott officially announced the cancellation of its decision to acquire US Airil. Fortune subsequently made a report explaining this. Today, I will take a look at this report with the readers and review the twists and turns.

Abbott said on Wednesday that it has initiated a termination process for the acquisition of the US Airil, because after Abbott’s decision to acquire the US company Aierel’s diagnostic company for 10 months, they assessed that the company’s valuation was “significant”. loss".

Abbott has filed a lawsuit in the courts of Delaware, France, to stop the transaction in late January 2017, which was valued at $5.8 billion at the beginning.

Mark Massaro of Jiatong Bexiang said in an interview with Reuters: "Abbott’s arrangement may be a stepping stone for its future price cuts."

He also said that Abbott’s best strategy is to create uncertainty and let the stock of the US Airil fall, and then the shareholders of the US Airil will accept a lower price. On the Thursday, US Airil was just accused of delaying the annual meeting.

Since Abbott and US Airil announced the deal earlier this year, the US Airil has faced multiple setbacks, and Abbott acquired St. Jude, a company focused on cardiac equipment production, for $25 billion in April.

Jeff Denhoy, an analyst at Jeffery Group, said: "After the announcement of the US Airil deal, Abbott expressed a lot of dissatisfaction and confession as a buyer." And the relationship between the two companies began to cool, Meiai Lear did not submit its financial statements on time and disclosed their accounts and overseas sales.

In July of this year, according to the requirements of the US health regulator, US Airil was recalled a device for monitoring the level of blood thinner, which is widely used, and this monitoring device was found to be A wrong monitoring result. In the following month, US Airil filed a lawsuit alleging that Abbott had dragged on the antitrust submission to try to destroy the transaction. Then in November, US Airil was not reimbursed in the federal health care business.

TCM Extract

Tcm Extract for traditonal medicine,Traditopnal Medicine For Sheep,Largehead Atractylodes Rhizome Extract powder

Sichuan Aibang Weiye Biological Engineering Co., Ltd. , https://www.aibangpharm.com